
ICU continuous glucose monitoring reduced hypoglycemia and increased time in range across 22 trials
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A meta-analysis of 22 randomized trials involving 1,396 adults in intensive care found that continuous glucose monitoring reduced hypoglycemic events and increased time in the target glucose range compared with intermittent monitoring.
What NurseJet pulled from the source
Across 22 randomized trials, continuous glucose monitoring was associated with fewer hypoglycemic events (risk ratio 0.41), 10.12 percentage points more time in the target range, lower average glucose, and less daily insulin use than intermittent monitoring. Pooled mortality was also lower, but the abstract does not report trial quality, device accuracy, care protocols, or the number of mortality events, so that estimate should not be interpreted as proof that monitoring alone improves survival.
Why this matters for nurses
ICU nurses manage insulin infusions, recognize hypoglycemia, validate unexpected readings, and coordinate rapid treatment changes. The pooled findings support continuous monitoring as a potentially useful addition to a protocolized glycemic-safety system while leaving device selection and confirmatory-testing requirements to local policy.
Bedside takeaway
Continuous glucose monitoring improved several pooled ICU glycemic measures, but treatment-changing readings still require protocol-based validation and response.
How This Applies in Practice
Use this when: Caring for an adult ICU patient whose glucose is being followed with an approved continuous monitor and protocolized insulin therapy.
On your shift
- Review glucose trends, alarms, nutrition, insulin delivery, perfusion, and medications together rather than responding to an isolated sensor value.
- Confirm unexpected, rapidly changing, or treatment-changing readings with the method required by the local ICU protocol.
- Document and escalate recurrent hypoglycemia, sensor-clinical discordance, interrupted nutrition, or insulin-delivery concerns.
Explain this for my unit
Key takeaways
- The meta-analysis included 22 randomized trials and 1,396 adult ICU patients.
- Continuous monitoring was associated with fewer hypoglycemic events and 10.12 percentage points more time in the target range.
- Average glucose and daily insulin use were lower with continuous monitoring.
- Heterogeneity was substantial for some glycemic outcomes, and the abstract provides limited detail about device performance, trial quality, or mortality events.
Practice implications
- Use continuous glucose data within the approved ICU insulin protocol, review trends and alarms alongside the patient's perfusion and medication status, and confirm unexpected or treatment-changing values as required. Escalate recurrent hypoglycemia, rapidly changing readings, or discordance with the clinical picture.
Limitations & cautions
- The included trials likely differed in devices, target ranges, insulin protocols, patient acuity, and confirmatory testing, and heterogeneity was substantial for average glucose and time in range. The abstract does not report risk-of-bias findings, device accuracy, adverse events, or mortality-event counts, so pooled survival results should be considered exploratory rather than causal.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Biological research for nursing (PubMed)
Biological research for nursing (PubMed). Continuous Glucose Monitoring for Adult ICU Patients: A Meta-Analysis on Its Clinical Effectiveness.
https://pubmed.ncbi.nlm.nih.gov/42486781/
Professional education only


